💊 ProspecteMedicamente.ro
Medicamente
Substanțe active
Clase ATC
Producători
Forme farmaceutice
OTC
Prospecte
🔍 Căutare
Medicamente
Substanțe active
Clase ATC
Producători
Forme farmaceutice
Fără rețetă (OTC)
Prospecte
🔍 Căutare
Acasă
›
Forme farmaceutice
›
Sol. Inj. in Stilou Injector Preumplut
Sol. Inj. in Stilou Injector Preumplut
99
medicamente sub formă de
sol. inj. in stilou injector preumplut
autorizate în România.
Denumire comercială
Substanță activă (DCI)
Concentrație
Producător
Cod ATC
AIMOVIG 140 mg
Erenumabum
140mg/ml
Novartis Pharma Gmbh - Germania
N02CD01
AIMOVIG 70 mg
Erenumabum
70mg/ml
Novartis Pharma Gmbh - Germania
N02CD01
APIDRA 100U/ml
Insulinum Glulizina
100U/ml
Sanofi-Aventis Deutschland Gmbh - Germania
A10AB06
ARANESP 100µg/0,5ml
Darbepoetinum Alfa
100µg/0,5ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 10µg/0,4ml
Darbepoetinum Alfa
10µg/0,4ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 130µg/0,65ml
Darbepoetinum Alfa
130µg/0,65ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 15µg/0,375ml
Darbepoetinum Alfa
15µg/0,375ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 20µg/0,5ml
Darbepoetinum Alfa
20µg/0,5ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 300µg/0,6ml
Darbepoetinum Alfa
300µg/0,6ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 30µg/0,3ml
Darbepoetinum Alfa
30µg/0,3ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 40µg/0,4ml
Darbepoetinum Alfa
40µg/0,4ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 500µg/ml
Darbepoetinum Alfa
500µg/ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 50µg/0,5ml
Darbepoetinum Alfa
50µg/0,5ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 60µg/0,3ml
Darbepoetinum Alfa
60µg/0,3ml
Amgen Europe Bv - Olanda
B03XA02
ARANESP 80µg/0,4ml
Darbepoetinum Alfa
80µg/0,4ml
Amgen Europe Bv - Olanda
B03XA02
BIMZELX 160 mg
Bimekizumabum
160mg/ml
Ucb Pharma S.a. - Belgia
L04AC21
BIMZELX 320 mg
Bimekizumabum
320mg/2ml
Ucb Pharma S.a. - Belgia
L04AC21
COSENTYX 150 mg
Secukinumabum
150mg/ml
Novartis Pharma Gmbh - Germania
L04AC10
COSENTYX 300 mg
Secukinumabum
300mg/2ml
Novartis Pharma Gmbh - Germania
L04AC10
FIASP 100 unitati/ml
Insulinum Aspart
100unitati/ml
Novo Nordisk a/S - Danemarca
A10AB05
GONAL-f 300 IU/0.48 ml (22 µg/0,48 ml)
Follitropinum Alfa
300UI/0,48ml
Merck Serono Spa - Italia
G03GA05
GONAL-f 450 IU/0.72 ml (33 µg/0,72 ml)
Follitropinum Alfa
450UI/0,72ml
Merck Serono Spa - Italia
G03GA05
GONAL-f 900 IU/1.44 ml (66 µg/1,44 ml)
Follitropinum Alfa
900UI/1,44ml
Merck Serono Spa - Italia
G03GA05
HUKYNDRA 40mg/0,4ml
Adalimumabum
40mg/0,4ml
Ivers-Lee Csm - Germania
L04AB04
HUKYNDRA 80mg/0,8ml
Adalimumabum
80mg/0,8ml
Ivers-Lee Csm - Germania
L04AB04
KESIMPTA 20mg
Ofatumumabum
50mg/ml
Novartis Pharma Gmbh - Germania
L04AG12
LANTUS SoloStar
Insulinum Glargine
100U/ml
Sanofi-Aventis Deutschland Gmbh - Germania
A10AE04
RYZODEG 100 unitati/ml
Combinatii (insulinum Degludec+insulinum Aspart)
100 unitati/ml (2,56mg+ 1,05mg)
Novo Nordisk a/S - Danemarca
A10AD06
SKYRIZI 150 mg
Risankizumabum
150mg/1ml
Abbvie S.r.l. - Italia
L04AC18
SUMATRIPTAN SUN 3 mg/0,5 ml
Sumatriptanum
3mg/0,5ml
Sun Pharmaceutical Industries Europe B.v. - Tarile de Jos
N02CC01
TAKHZYRO 300 mg
Lanadelumabum
300mg
Shire Pharmaceuticals Ireland Limited - Irlanda
B06AC05
TRESIBA 100 unitati/ml
Insulinum Degludec
100 UI/ml
Novo Nordisk a/S - Danemarca
A10AE06
VICTOZA 6 mg/ml
Liraglutidum
6 mg/ml
Novo Nordisk a/S - Danemarca
A10BJ02
XOLAIR 150 mg
Omalizumabum
150mg
Novartis Pharma Gmbh - Germania
R03DX05
XOLAIR 300 mg
Omalizumabum
300mg
Novartis Pharma Gmbh - Germania
R03DX05
XOLAIR 75 mg
Omalizumabum
75mg
Novartis Pharma Gmbh - Germania
R03DX05
YUFLYMA 40mg/0,4ml
Adalimumabum
40mg/0,4ml
Millmount Healthcare Limited - Irlanda
L04AB04
Forme similare
Sol. Inj.
(780)
Sol. Perf.
(752)
Sol. Inj. in Seringa Preumpluta
(579)
Conc. Pt. Sol. Perf.
(462)
Sol. Inj./Perf.
(288)
Pulb. Pt. Sol. Inj./Perf.
(255)